License-Out
License Agreement Has Been Entered into with RheinCell Therapeutics
We have executed a non-exclusive license agreement with RheinCell Therapeutics GmbH (Germany) for conducting a GMP-grade iPS cell bank consisting of various cord blood derived so-called HLA-homozygous cells under the patents on iPS cell technologies licensed to us by Kyoto University.
